Market Cap (In USD)
9.01 Million
Revenue (In USD)
-
Net Income (In USD)
-2536.23
Avg. Volume
9.66 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.047-12.8
- PE
- -
- EPS
- -
- Beta Value
- -0.463
- ISIN
- US71902K1051
- CUSIP
- -
- CIK
- 1870404
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Brian G. Atwood
- Employee Count
- -
- Website
- https://www.cero.bio
- Ipo Date
- 2021-11-30
- Details
- CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
More Stocks
-
PKPYY
-
GUJTLRMGujarat Toolroom Limited
GUJTLRM
-
BCE-PABCE Inc.
BCE-PA
-
GELGel S.p.A.
GEL
-
ASHLAshley Gold Corp.
ASHL
-
600446
-
VSME
-
CIC